Skip to content

UNITED HEALTH PRODUCTS, INC.: 10-K filed 2020-07-09

What UNITED HEALTH PRODUCTS, INC. reported in its annual report filed 2020-07-09 (fiscal FY 2019): 32 published measures, 96 facts as tagged in accession 0001477932-20-003845.

This filing

Form
10-K (annual report)
Filed
2020-07-09
Fiscal period
fiscal FY 2019
Accession
0001477932-20-003845 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All UNITED HEALTH PRODUCTS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-12-3193,472USD
At 2018-12-31113,253USD
At 2017-12-31239,818USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-12-31997,277USD
At 2018-12-31263,947USD
At 2017-12-31792,173USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-12-31-903,805USD
At 2018-12-31-150,694USD
At 2017-12-31-552,355USD
At 2016-12-31-546,045USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-12-3116,624USD
At 2018-12-3131,273USD
At 2017-12-31189,942USD
At 2016-12-3129,367USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-6,602,295USD365
2018-01-01 to 2018-12-31-5,402,369USD365
2017-01-01 to 2017-12-31-1,466,789USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-1,766,764USD365
2018-01-01 to 2018-12-31-1,278,662USD365
2017-01-01 to 2017-12-31-649,675USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-01-01 to 2019-12-314,927USD365
2018-01-01 to 2018-12-3134,876USD365
2017-01-01 to 2017-12-31183,174USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-12-311,752,115USD365
2018-01-01 to 2018-12-311,119,993USD365
2017-01-01 to 2017-12-31810,250USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-12-310USD365
2018-01-01 to 2018-12-310USD365
2017-01-01 to 2017-12-310USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-12-31-26,127,859USD
At 2018-12-31-19,525,564USD
At 2017-12-31-14,123,195USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-01-01 to 2019-12-310USD365
2018-01-01 to 2018-12-310USD365
2017-01-01 to 2017-12-310USD365

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-12-313,880,250USD365
2018-01-01 to 2018-12-31697,000USD365
2017-01-01 to 2017-12-31144,000USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-6,094,112USD365
2018-01-01 to 2018-12-31-1,896,974USD365
2017-01-01 to 2017-12-31-928,418USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-12-3193,472USD
At 2018-12-31113,253USD
At 2017-12-31239,818USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-01-01 to 2019-12-31508,183USD365
2018-01-01 to 2018-12-310USD365
2017-01-01 to 2017-12-3139,479USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-12-31997,277USD
At 2018-12-31263,947USD
At 2017-12-31792,173USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-12-310USD
At 2018-12-310USD
At 2017-12-31371USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-01-01 to 2019-12-316,097,723USD365
2018-01-01 to 2018-12-311,909,580USD365
2017-01-01 to 2017-12-311,010,603USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-12-3176,848USD
At 2018-12-3131,980USD
At 2017-12-3137,391USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-01-01 to 2019-12-313,611USD365
2018-01-01 to 2018-12-3112,606USD365
2017-01-01 to 2017-12-3182,185USD365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-01-01 to 2019-12-311,316USD365
2018-01-01 to 2018-12-3122,270USD365
2017-01-01 to 2017-12-31100,989USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-01-01 to 2019-12-315,431,335USD365
2018-01-01 to 2018-12-311,832,629USD365
2017-01-01 to 2017-12-31990,667USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-01-01 to 2019-12-31666,388USD365
2018-01-01 to 2018-12-3176,951USD365
2017-01-01 to 2017-12-3119,936USD365

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-12-3125,045,754USD
At 2018-12-3119,200,927USD
At 2017-12-3113,405,688USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-12-31119,016USD
At 2018-12-3136,556USD
At 2017-12-31108,055USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2019-12-310USD
At 2018-12-310USD
At 2017-12-310USD

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-508,183USD365
2018-01-01 to 2018-12-31-3,505,395USD365
2017-01-01 to 2017-12-31-538,371USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2019-01-01 to 2019-12-310USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-12-310USD365
2018-01-01 to 2018-12-310USD365
2017-01-01 to 2017-12-3116,000USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-01-01 to 2019-12-311,255,750USD365
2018-01-01 to 2018-12-311,415,200USD365
2017-01-01 to 2017-12-31644,000USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-12-310USD365
2018-01-01 to 2018-12-31371USD365
2017-01-01 to 2017-12-3199,910USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-44,868USD365
2018-01-01 to 2018-12-315,411USD365
2017-01-01 to 2017-12-31-71,040USD365

Inspect the source

Entity
UNITED HEALTH PRODUCTS, INC. / CIK 0001096938
Captured
2026-09-20T05:22:35.874Z
SEC response SHA-256
ac6cf9d703c0adca8f17a2c8b6ab295df7496239afbd8b7d9c595d23b1e2267e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001096938.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))